Synovial fluid analysis for diagnosis of intercritical gout.
about
A proposed classification of the immunological diseasesThe urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trialGout in solid organ transplantation: a challenging clinical problem.Dietary supplements for chronic goutDietary supplements for chronic goutEULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)Gout: optimizing treatment to achieve a disease cureThe first metatarsophalangeal joint in gout: a systematic review and meta-analysisA review of uric acid, crystal deposition disease, and gout.Clinical factors and treatment outcomes associated with failure in the detection of urate crystal in patients with acute gouty arthritis.Identification of crystals in synovial fluids and joint tissues.Pathogenesis of crystal-induced inflammation.Overview of Serum Uric Acid Treatment Targets in Gout: Why Less Than 6 mg/dL?The value of synovial fluid assays in the diagnosis of joint disease: a literature survey.Role of the NLRP3 inflammasome in the transient release of IL-1β induced by monosodium urate crystals in human fibroblast-like synoviocytes.Diagnosis and management of gout: a rational approachIntracellular and extracellular CPPD crystals are a regular feature in synovial fluid from uninflamed joints of patients with CPPD related arthropathy.Validity of gout diagnosis in Swedish primary and secondary care - a validation study.Update on identification of pathogenic crystals in joint fluid.Characteristics of the first metatarsophalangeal joint in gout and asymptomatic hyperuricaemia: a cross-sectional observational studyAre joints affected by gout also affected by osteoarthritis?Concordance of the management of chronic gout in a UK primary-care population with the EULAR gout recommendations.Wide-field imaging of birefringent synovial fluid crystals using lens-free polarized microscopy for gout diagnosis.Mechanisms of inflammation in gout.Refractory gout attack.Latest evidence on gout management: what the clinician needs to knowPathophysiology, clinical presentation and treatment of gout.Management of gout in older adults: barriers to optimal control.Why is gout so poorly managed?Lowering serum uric acid levels: what is the optimal target for improving clinical outcomes in gout?Management of gout.Arthrocentesis and synovial fluid analysis in clinical practice: value of sonography in difficult cases.Targeting inflammasomes in rheumatic diseases.The distribution of urate deposition within the extremities in gout: a review of 148 dual-energy CT cases.Mechanisms of crystal formation in gout-a structural approach.Role of miR-146a in regulation of the acute inflammatory response to monosodium urate crystals.Gout: An old disease in new perspective - A review.Advanced erosive gout as a cause of Fever of unknown origin.Effects of bariatric surgery on gout incidence in the Swedish Obese Subjects study: a non-randomised, prospective, controlled intervention trial.Time required for disappearance of urate crystals from synovial fluid after successful hypouricaemic treatment relates to the duration of gout.
P2860
Q21144701-ED3437B4-5E05-4541-8BE9-5D8BAC84BE4EQ21195361-0CEA6474-BFA9-4479-ABEF-BAFF7B9FE43AQ22305834-B0A7BAE7-CBE5-4FC8-8664-BD80CF31A6AAQ24193159-AB7D9B47-57A9-4D8B-8D4C-74115EB6CE2DQ24197922-AFCAF7F3-0366-46F1-8A27-1351F53F1DFBQ24675089-F2BB2913-D2AE-4942-AFEA-7D5A39EE3E3FQ26765550-972A1804-69AC-4204-A49D-4D26F439710CQ28069828-7F60922C-FDB3-4732-91CC-196B888B1D78Q30619265-F7C7412C-84C9-4455-BDD6-587038091934Q33639635-B56BF197-1AA2-4A84-BB39-C9EB23634C17Q34140969-F95AB197-FFC8-455F-8743-ADDCB0267528Q34140978-43315965-F8AE-49B9-A074-5970F9B92489Q34538414-E865D640-BD7D-4215-9A01-489E6BF924ACQ34634730-73B1B180-A38C-4A47-813A-257F5A7F6FD3Q35495434-528FDA1F-9A0A-43C9-9574-2DDC8E9376A9Q35522716-4790A492-E9CA-4DA3-9B2A-C36E63D85347Q35555087-0494B81A-512A-461D-B009-80C42863ED98Q35664481-412EC9DC-4258-4585-9C50-2656E3BCC304Q35768689-B56B97DD-A315-442E-A2F4-332B70BE42BCQ35964755-B5AA169F-7A92-4DA2-A8D4-69948185F47FQ36013839-1188CFE7-634E-4C5B-9B90-DAF5EEBFDB93Q36013873-599B25CB-C764-4D8B-8C15-FD923135E82AQ36064155-EF985B4C-1E91-4901-B5A4-3BFC9E2E21BDQ36163163-2C221286-9EAA-43E4-A27C-E78EF81B51ADQ36469680-79007E69-8343-4231-9FA9-8C5C127799CBQ36515484-FB05C875-C7DA-477F-8594-BE58AAC37D06Q36586895-D696BFB6-EF2A-47E9-AFD8-0936457EE777Q36711176-0D0FC63B-0CA9-48E2-ABE5-00F431BD2122Q36946394-CDA774E1-656B-428F-843F-11D6F5BE536DQ36956486-A0EB28B8-AB71-46C5-B792-590786178E52Q37139512-7702CC28-7BB0-4BEC-9D47-2DC436108470Q37403701-0BE32A25-A18C-475F-B71B-226E136BA0EFQ38106621-AD2285AE-2B06-41C5-8DD6-1F375C24E812Q38171281-3599BCC1-8C4D-402C-8BE8-D8C321B9493AQ38586640-73C51C20-9047-4CC2-B155-4C43EDD5967EQ38913622-EFF2E413-4999-471F-8FC0-4F6719C903B0Q40106739-9F182E63-3FCB-4B1E-9A5D-5F038526601EQ40154098-D5BE3747-59CB-4AC2-9E16-BF209D5449F5Q40385980-8E5F2490-4ACD-4461-B8EF-A98EDB6A37FFQ41970890-4FDF6B91-827B-4526-A111-6CC561FC3E8B
P2860
Synovial fluid analysis for diagnosis of intercritical gout.
description
1999 nî lūn-bûn
@nan
1999 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Synovial fluid analysis for diagnosis of intercritical gout.
@ast
Synovial fluid analysis for diagnosis of intercritical gout.
@en
type
label
Synovial fluid analysis for diagnosis of intercritical gout.
@ast
Synovial fluid analysis for diagnosis of intercritical gout.
@en
prefLabel
Synovial fluid analysis for diagnosis of intercritical gout.
@ast
Synovial fluid analysis for diagnosis of intercritical gout.
@en
P2093
P1476
Synovial fluid analysis for diagnosis of intercritical gout
@en
P2093
A Martínez
E Batlle-Gualda
P304
P356
10.7326/0003-4819-131-10-199911160-00007
P407
P577
1999-11-01T00:00:00Z